For example, in breast cancer, downregulation of K18 is significantly correlated with advanced tumor stage and shorter patient survival [28], but studies examining K5, K14, and K17 have shown that overexpression of these proteins are associated with poor patient prognoses across various cancer types [29,30,31]. The gene discussed is KRT18; the disease is cancer.